Navigation Links
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
Date:5/9/2013

g that the test can now be used to predict progression risk to choroidal neovascularization (CNV) or late stage '"wet" AMD in patients with early stage disease.

Sequenom CMM had a strong presence during the annual clinical meeting of the American College of Medical Genetics and Genomics in March, during which NIPT was a prominent topic.  Sequenom CMM hosted a dynamic symposium on NIPT attended by approximately 700 medical professionals and presented a series of posters highlighting its clinical experience with the first 60,000 MaterniT21 PLUS test samples processed.

Sequenom CMM also accessioned a record number of patient samples for cystic fibrosis testing, based on the introduction of the Heredi-T™ cystic fibrosis (CF) carrier screening test.  The Heredi-T CF laboratory-developed test now analyzes 136 mutations and five variants proven to be clinically relevant in causing CF, integrating disease causing mutations selected from the Johns Hopkins CFTR2 database.  The test analyzes nearly six times the number of clinically relevant mutations currently available in the most common commercial CF carrier screening test methods.

In response to the growing commercial interest and demand for its testing services, Sequenom CMM expanded its diagnostics sales force during the first quarter of 2013, bringing the total to approximately 84 diagnostic sales representatives actively selling in all 50 states.  The Company continues to expand into international markets as well.

Sequenom CMM has implemented an in-house billing system, effective May 1, 2013, utilizing a leading hosted software solution.  This new system is expected to enable Sequenom CMM to maximize reimbursement, improve cash flow and improve efficiencies in the billing and collections process.

Sequenom CMM has completed the build-out and validation of the additional laboratory location in North Carolina, which has recen
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
2. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
3. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
4. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
5. Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
7. Chindex International, Inc. Reports First Quarter 2013 Financial Results
8. BioScrip Reports First Quarter 2013 Financial Results
9. China Biologic Reports Financial Results for the First Quarter of 2013
10. Nephros Reports First Quarter 2013 Financial Results
11. PharmAthene Reports First Quarter 2013 Financial And Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  eRelevance Corporation ( www.erelevancecorp.com ), a ... it has completed integration with Nextech, a popular ... and Dermatology practices. "Integration allows our ... practices using Nextech," stated Bob Fabbio , ... from the EMR we are able to automatically ...
(Date:8/21/2014)... Aug. 21, 2014  Publicis Groupe customer engagement ... Managing Partner and Healthcare Industry Group Leader, has been ... recognizes the most inspiring people in the life-sciences industry. ... research and development, marketing, technology, creativity, strategy and medicine. ... as a partner in its leading Rosetta Consulting practice. ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - The Canadian Epilepsy ... new comic series designed to educate children about the most ... The Medikidz Explain Epilepsy comic series tells a ... is navigating middle school while living with epilepsy. ... Canadians, there is still so much misinformation and lack of ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3
... Oncology Group -, BRISBANE, Calif., May 28 ... its clinical trials program through the,initiation of an ... candidate,BSI-201. The trial will assess BSI-201, the first ... portfolio, for the treatment,of uterine carcinosarcoma or malignant ...
... FDA Approval Based on Updated Results Showing a 20% Reduction ... a 22% Improvement of Disease Free Survival at ... III Colon Cancer, Post Surgery -, BRIDGEWATER, N.J., May ... Drug Administration (FDA) approved,the supplemental new drug application (sNDA) to ...
Cached Medicine Technology:BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4
(Date:8/22/2014)... Dayton Children's Hospital broke ground on a ... a $141 million campus renewal. Renderings of ... to the public. , The new patient tower is ... a campus that meets the needs of patients, families and ... will embody Dayton Children’s unique patient care mission and offer ...
(Date:8/22/2014)... again attained the distinguished Magnet hospital designation by ... Program. Considered the gold standard for nursing excellence, ... and professionalism. It is the top international credential ... redesignate Newport Hospital was based on the hospital,s ... practice. , "It is a privilege for us ...
(Date:8/22/2014)... who use reduced-nicotine cigarettes don,t smoke more to make ... a new study. This means they don,t inhale ... The month-long study included 72 adult smokers, aged ... emission levels of 1.2 milligrams (mg) each for one ... the next three weeks. In each of those ...
(Date:8/22/2014)... 2014 (HealthDay News) -- Inner city children have a higher-than-normal ... Researchers followed 516 inner city children in four U.S. cities ... birth until age 5 and found that at least 10 ... peanuts. Because only the three most common types of ... of inner city youngsters with food allergies may be even ...
(Date:8/22/2014)... A new, online conference is coming August 25th-29th, ... no-cost and open to everyone. Over 20 top experts ... advice on how to stop emotional eating, start eating healthier ... eating is not a diet. The concept is about how ... "eat this, don't eat that" approach. , You can sign ...
Breaking Medicine News(10 mins):Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Low-Nicotine Cigarettes May Not Lead to More Smoking 2Health News:Food Allergies More Common Among Inner City Kids, Study Finds 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2
... For the first time, families of murder victims have joined ... executed to speak out against the death penalty. , ... at a special session on the first day of the ... calls the death penalty "inappropriate and unwarranted" for people with ...
... July 6 NeoStem, Inc. (Amex: NBS ... long-term storage of adult stem cells for future medical ... M.D., Ph.D., FACP, FRCP, as the Company,s Vice President ... Among his responsibilities in this position will be overseeing ...
... MINNEAPOLIS, July 6 ATS Medical, Inc. (Nasdaq: ... state-of-the-art cardiac surgery products and services, today announced ... ATS Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid ... with Genesee BioMedical and represents the latest addition ...
... ... 20/20 vision after submitting the winning video for a contest sponsored by a prominent ... to a stranger can brighten someone’s day. , ... (Vocus) July 6, 2009 -- In tough times, random acts of kindness ...
... In ... American Orthopaedic Society for Sports Medicine (AOSSM) will present eight research awards and ... ... order to recognize and encourage cutting-edge research in key areas of orthopaedic sports medicine, the ...
... acute hunger and undernutrition occurs not in conflicts and ... to an article published this week in open access ... the time of year when the previous year,s harvest ... are scarce, and is often under recognized. Bapu ...
Cached Medicine News:Health News:Death Penalty and Mental Illness: Families of Victims Speak out at National Convention; 'Double Tragedies' Report Released 2Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 2Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 3Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 4Health News:ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band 2Health News:ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band 3Health News:Eye Doctors of Washington Awards DC Resident Free LASIK as Part of its Good Deeds Campaign 2Health News:Eye Doctors of Washington Awards DC Resident Free LASIK as Part of its Good Deeds Campaign 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Round handle manufactured in titanium....
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Flat handle....
McPherson handle. 45 degree angled shafts. Manufactured in titanium....
This cross action forcep has delicate tips for grasping the capsule. The forcep has an iris stop to prevent inadvertent grasping of the iris....
Medicine Products: